Metzger T - Search Results

1

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Zimmermann J, et al. Among authors: metzger t. Kidney Int. 1999 Feb;55(2):648-58. doi: 10.1046/j.1523-1755.1999.00273.x. Kidney Int. 1999. PMID: 9987089 Free article.

2

Lipid changes and statins in chronic renal insufficiency and dialysis.

Wanner C, Krane V, Metzger T, Quaschning T. Wanner C, et al. Among authors: metzger t. J Nephrol. 2001 Nov-Dec;14 Suppl 4:S76-80. J Nephrol. 2001. PMID: 11798151 Review.

3

Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.

Quaschning T, Krane V, Metzger T, Wanner C. Quaschning T, et al. Among authors: metzger t. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S14-9. doi: 10.1053/ajkd.2001.27384. Am J Kidney Dis. 2001. PMID: 11576915 Review.

4

Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage?

Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C. Stenvinkel P, et al. Among authors: metzger t. Kidney Int. 2002 Nov;62(5):1791-8. doi: 10.1046/j.1523-1755.2002.00637.x. Kidney Int. 2002. PMID: 12371981 Free article.

5

Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia.

Ketteler M, Wanner C, Metzger T, Bongartz P, Westenfeld R, Gladziwa U, Schurgers LJ, Vermeer C, Jahnen-Dechent W, Floege J. Ketteler M, et al. Among authors: metzger t. Kidney Int Suppl. 2003 May;(84):S84-7. doi: 10.1046/j.1523-1755.63.s84.21.x. Kidney Int Suppl. 2003. PMID: 12694317 Free article. Review.

6

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J. Ketteler M, et al. Among authors: metzger t. Lancet. 2003 Mar 8;361(9360):827-33. doi: 10.1016/S0140-6736(03)12710-9. Lancet. 2003. PMID: 12642050

7

C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.

Wanner C, Metzger T. Wanner C, et al. Among authors: metzger t. Nephrol Dial Transplant. 2002;17 Suppl 8:29-32; discussion 39-40. doi: 10.1093/ndt/17.suppl_8.29. Nephrol Dial Transplant. 2002. PMID: 12147774 Review.

8

Inflammation and cardiovascular risk in dialysis patients.

Wanner C, Zimmermann J, Schwedler S, Metzger T. Wanner C, et al. Among authors: metzger t. Kidney Int Suppl. 2002 May;(80):99-102. doi: 10.1046/j.1523-1755.61.s80.18.x. Kidney Int Suppl. 2002. PMID: 11982822 Free article.

9

Advanced glycation end products and mortality in hemodialysis patients.

Schwedler SB, Metzger T, Schinzel R, Wanner C. Schwedler SB, et al. Among authors: metzger t. Kidney Int. 2002 Jul;62(1):301-10. doi: 10.1046/j.1523-1755.2002.00423.x. Kidney Int. 2002. PMID: 12081592 Free article.

10

Lipid lowering in end-stage renal disease.

Wanner C, Metzger T, Krane V. Wanner C, et al. Among authors: metzger t. Saudi J Kidney Dis Transpl. 2001 Jan-Mar;12(1):3-8. Saudi J Kidney Dis Transpl. 2001. PMID: 18209353 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results